SR Medical Technology Company Limited

As of December 31, 2025, SR Medical Technology Company Limited carries a market capitalization of 7.50B, placing it among publicly traded companies globally. Its enterprise value stands at 10.27B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

As of December 31, 2025, SR Medical Technology Company Limited has 3.22B shares outstanding.

These figures are as of December 31, 2025.

As of December 31, 2025, SR Medical Technology Company Limited maintains a current ratio of 0.55, meaning it holds 0.6x the short-term assets needed to cover near-term liabilities.

These figures cover the twelve months ended December 31, 2025.

As of the close on October 22, 2026, SR Medical Technology Company Limited's stock has gained approximately 23.20% over the past 52 weeks. The 50-day moving average sits at 2.07, while the 200-day moving average is 2.33.

As of December 31, 2025, SR Medical Technology Company Limited holds 121.22M in cash and equivalents against 2.89B in total debt, resulting in a net debt position of 2.76B. Total book value stands at 2.09B, with working capital of -838.08M providing operational flexibility.

SR Medical Technology Company Limited's most recent stock split took place on June 5, 2018 with a 242:243 split ratio.